Published in Viewp Dig Dis on September 01, 1979
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet (1979) 2.51
Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol (1975) 2.42
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Growth stimulation in the liver and tumour development following intraperitoneal injections of liver homogenates in the rat. Acta Pathol Microbiol Scand Suppl (1957) 1.27
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96
Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04
The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02
Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation (1967) 0.96
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95
Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology (2013) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
The treatment of penetrating wounds of the inferior vena cava. Surgery (1962) 0.86
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant (1991) 0.82
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation (2006) 0.82
Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood (2006) 0.82
Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81
Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant (1989) 0.81
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80
Tolerance for organ recipients: a clash of paradigms. Liver Transpl (2006) 0.78
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78
Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant (2006) 0.78
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci (1993) 0.78
The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation (2006) 0.78
Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation (2009) 0.78
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation (2007) 0.78
LIVER TRANSPLANTATION IN MAN. Ann N Y Acad Sci (1970) 0.78
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant (1992) 0.78
Kidney/Bone Marrow Transplantation. Dial Transplant (1996) 0.76
Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation (2008) 0.75
Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation (2007) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
LONG TERM RESULTS OF HEPATIC TRANSPLANTATION DURING THE CYCLOSPORINE ERA: THE PITTSBURGH EXPERIENCE. Transplant Clin Immunol (1987) 0.75
Transplantation. JAMA (1986) 0.75
CRITICAL CARE MEDICINE AND LIVER TRANSPLANTATION. Crit Care (1985) 0.75
World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75
The Problem of Frostbite in Civilian Medical Practice. Surg Clin North Am (1963) 0.75
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant (1993) 0.75
Effect of homograft ischemia upon serum proteins after orthotopic liver transplantation. Surgery (1968) 0.75
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75
Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment? Clin Immunother (1996) 0.75
Blood Vessel Bank: Organization and Function. Bull Univ Miami Sch Med Jackson Meml Hosp (1957) 0.75
Successful salvage of mucormycosis infection of the forearm and osteomyelitis of the ulna. Hand (N Y) (2008) 0.75
Causes of death after liver transplantation in children treated with cyclosporine and steroids. Clin Transplant (1989) 0.75
Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant (1987) 0.75
Pancreatic complications following orthotopic liver transplantation. Clin Transplant (1992) 0.75
Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. Cleve Clin J Med (2008) 0.75
Recurrent liver disease after liver transplantation. Forum (Genova) (1997) 0.75
Fifty years later. Clin Transpl (2013) 0.75